| Cash Flow | 2025-11-30 | 2025-08-31 | 2025-05-31 | 2024-11-30 |
|---|---|---|---|---|
| Net earnings | - | 305,759 | 210,381 | 410,690 |
| Depreciation and amortization | - | 163,715 | 79,784 | 217,332 |
| Share-based compensation expense | - | 71,255 | 46,981 | 107,121 |
| Provision for loan losses | - | - | - | 266,406 |
| Provision for loan, lease, and other losses | - | 243,904 | 101,707 | - |
| Provision for cancellation reserves | - | 41,897 | 24,803 | 75,007 |
| Deferred income tax provision (benefit) | - | 42,424 | 2,782 | -19,961 |
| Other | - | -1,393 | -1,310 | -6,186 |
| Accounts receivable, net | - | -15,177 | 11,572 | -19,872 |
| Financing receivable, held-for-sale, not part of disposal group, reconciliation to cash flow, period increase (decrease) | - | 921,928 | 637,947 | - |
| Inventory | - | -785,052 | -310,269 | -12,907 |
| Other current assets | - | -6,331 | -2,692 | -127,978 |
| Auto loans held for investment, net | - | -612,649 | -338,338 | 667,502 |
| Other assets | - | 13,889 | 5,712 | 13,936 |
| Accounts payable, accrued expenses and other current liabilities and accrued income taxes | - | -230,470 | -141,867 | 6,695 |
| Other liabilities | - | -38,232 | -22,406 | -70,733 |
| Cash provided by (used in) operating activity, including discontinued operation | 2,338,114 | 1,085,037 | 299,543 | 478,062 |
| Capital expenditures | 407,962 | 268,204 | 136,736 | 340,322 |
| Proceeds from disposal of property and equipment | 385 | 348 | 48 | 153 |
| Purchases of investments | 8,754 | 5,765 | 4,926 | 9,478 |
| Sales and returns of investments | 1,922 | 1,155 | 425 | 1,722 |
| Cash provided by (used in) investing activity, including discontinued operation | -411,277 | -272,466 | -141,189 | -347,925 |
| Proceeds from issuances of long-term debt | 87,000 | 87,000 | 87,000 | 34,400 |
| Payments on long-term debt | 299,007 | 94,955 | 90,930 | 344,231 |
| Cash paid for debt issuance costs | 18,555 | 13,279 | 8,895 | 16,861 |
| Payments on finance lease obligations | 11,002 | 7,105 | 3,443 | 13,146 |
| Issuances of non-recourse notes payable | 9,577,170 | 6,848,169 | 3,988,864 | 9,721,000 |
| Payments on non-recourse notes payable | 10,729,859 | 6,911,012 | 3,906,323 | 9,491,659 |
| Repurchase and retirement of common stock | 588,440 | 384,873 | 204,027 | 329,581 |
| Equity issuances | 8,349 | 8,349 | 8,329 | 35,367 |
| Cash provided by (used in) financing activity, including discontinued operation | -1,974,344 | -467,706 | -129,425 | -404,711 |
| Decrease in cash, cash equivalents, and restricted cash | -47,507 | 344,865 | 28,929 | -274,574 |
| Cash and cash equivalents at beginning of period | 960,310 | 960,310 | 960,310 | 1,250,410 |
| Cash and cash equivalents at end of period | 912,803 | 1,305,175 | 989,239 | 975,836 |
CARMAX INC (KMX)
CARMAX INC (KMX)